Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2026)

Rezolute's (RZLT) quarterly Other Non-Current Liabilities came in at $483000.0 in Q1 2026, little changed year-on-year from $483000.0 in Q1 2025, and little changed quarter-over-quarter from $483000.0 in Q4 2025.

Rezolute (RZLT) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends

Rezolute has disclosed Other Non-Current Liabilities across 13 years of filings, most recently posting $483000.0 for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $483000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $483000.0 (changed 0.0% YoY), and the FY2025 annual result was $468000.0, changed 0.0% from the prior year.
  • Other Non-Current Liabilities came in at $483000.0 for Q1 2026 at Rezolute, roughly flat from $483000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $483000.0 in Q3 2024 to a low of $395000.0 in Q1 2022.
  • The 5-year median for Other Non-Current Liabilities is $453000.0 (2024), against an average of $450647.1.
  • Across the five-year window, Other Non-Current Liabilities increased 13.59% in 2024 and changed 0.0% in 2025, its largest moves.
  • Rezolute's Other Non-Current Liabilities stood at $434000.0 in 2022, then rose by 1.15% to $439000.0 in 2023, then climbed by 8.66% to $477000.0 in 2024, then climbed by 1.26% to $483000.0 in 2025, then changed by 0.0% to $483000.0 in 2026.
  • The last three Other Non-Current Liabilities figures came in at $483000.0 (Q1 2026), $483000.0 (Q4 2025), and $483000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Rezolute 520.13 Mn 520.13 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 483,000.00
Dec 31, 2025 483,000.00
Sep 30, 2025 483,000.00
Jun 30, 2025 468,000.00
Mar 31, 2025 483,000.00
Dec 31, 2024 477,000.00
Sep 30, 2024 483,000.00
Jun 30, 2024 468,000.00
Mar 31, 2024 453,000.00
Dec 31, 2023 439,000.00
Sep 30, 2023 426,000.00
Jun 30, 2023 412,000.00
Mar 31, 2023 447,000.00
Dec 31, 2022 434,000.00
Sep 30, 2022 420,000.00
Jun 30, 2022 407,000.00
Mar 31, 2022 395,000.00
Dec 31, 2021 383,000.00
Sep 30, 2021 371,000.00
Jun 30, 2021 387,000.00